March 6 (Reuters) - Cell Therapeutics Inc:
* Says received from spectrum $6.5 million of the purchase price for selling
stake in zevalin venture
* Says will continue to be listed on NASDAQ capital market
((New York Equities Desk; tel: +1 646 223 6000))
(For more news about Cell Therapeutics Inc click here:) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Says received from spectrum $6.5 million of the purchase price for selling
stake in zevalin venture
* Says will continue to be listed on NASDAQ capital market
((New York Equities Desk; tel: +1 646 223 6000))
(For more news about Cell Therapeutics Inc click here:) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.